Anastasia Gutierrez Email

VP Clinical Operations . Immuneering Corporation

Current Roles

Employees:
89
Revenue:
$13.8M
About
Immuneering leverages more than a decade of leadership in bioinformatics to develop new medicines unlikely to be found by traditional drug discovery methods. Its current pipeline of drug candidates is focused on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. Utilizing its proprietary Disease Cancelling Technology, the company engineers medicines that reverse a disease signal across many relevant genes. Immuneering's technologies have proven exceptionally rapid and capital-efficient in creating its pipeline. Concurrent with its internal programs, the company provides unparalleled computational biology services to leading pharmaceutical and biotechnology companies.
Immuneering Corporation Address
245 Main St
Cambridge, MA
United States
Immuneering Corporation Email

Past Companies

Immuneering CorporationVice President Clinical Operations
Bellicum Pharmaceuticals, Inc.Senior Director, Clinical and Safety Operations
Bellicum Pharmaceuticals, Inc.Director Clinical and Safety Operations

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.